Bharat Book

Conference on 6th Annual Drug Delivery Systems

Event

01
FEB
BSG Conference Centre, London, UK
-   -

Conference on 6th Annual Drug Delivery Systems
To be held at 1st - 2nd February 2011, BSG Conference Centre, London, UK

Key Speakers at Conference on 6th Annual Drug Delivery Systems :

Dr. Sven Stegemann, Director, Pfizer
Dr. Sophie Van Tomme, Pharmaceutical Scientist, Abbott
Gerrit Hauck, Head PSD R&D Operations, Sanofi -Aventis
Matthew Roe, Senior Director-Business Development and Licensing, Genzyme
Dr. Oliver Steinbach, Department Head, Philips Research Laboratories
Dr. Rajan K. Verma, Senior Manager Early Development Formulations – Generics Integrated Product Development (IPDO), Dr Reddy’s Laboratories
Dr. Deirdre McIntosh, Director, McIntosh Scientific Advice Services
Dr. Michel Deleers, CEO, OncoBel
Dr. Andrew Lewis, Operations Director, Critical Pharmaceuticals
Dr. Ben Forbes, Senior Lecturer in Pharmaceutics, King’s College, London
Ketan Pancholi, Lecturer, The Robert Gordon University
Gerry Kamstra Partner, IP & Life Sciences, Bird and Bird

Conference on 6th Annual Drug Delivery Systems Introduction

Shrinking global capital markets, new healthcare policies, ageing populations, the growth of emerging economies, technological advances and the advent of regenerative and biological medicines are just some of the factors expected to shape the future drug delivery device market. (Source: Cambridge Consultants UK, September 2009)

With increased competition and the growing importance of patience compliance, pharmaceutical companies are working towards developing effective and targeted drug
delivery systems, to transform disease treatments. Now in its 6th year, Drug Delivery Systems Conference showcases the basics and latest developments for inhaled drug, RNAi based therapies and protein and peptide methods. We have put together an unparalleled scientific programme comprising insightful presentations by leading experts from Pfizer, Philips Research, Dr Reddy’s Laboratories and Genzyme. This conference will feature keynote addresses, case studies and interactive discussions
ranging from current and evolving drug delivery technologies to advancement and manufacturing of more efficient formulations.

Attendance at Conference on 6th Annual Drug Delivery Systems will enable you to:

Benefit from thorough updates of recent developments in the drug delivery sector
Examine challenges in generic development of drug delivery systems
Learn from in-depth case study from Philips about image-guided ultrasound-mediated drug delivery
Identify different strategies in managing a drug delivery alliance
Know how to overcome the industry challenges for inhaled delivery systems
Discuss key regulatory and legal issues
Recognise the importance of new biologic delivery technologies
Discuss microbubble production technologies and its effect on delivery
Create patient centered drug delivery product
Network with experts and opinion leaders from pharma, biotech, device and drug delivery industries

Who should attend Conference on 6th Annual Drug Delivery Systems ?

VPs, Directors, Heads, Managers of:

Drug Delivery
Preformulation /Formulation/Stability
Business Development
Licensing
Technology Assessment
Commercial Development
Patents
Lifecycle Management
Strategic Planning and Development
Financial Analyst
Pharmaceutical and Analytical R&D
Pharmaceutical Science
Testing
Product Development
New Product Planning]
New Technology Evaluation
Marketing
Brand Management
Product Management
Sales
Regulatory Affairs
Others:
Intellectual Property Attorneys
Venture Capitalists
Medical Device Companies
Analysts/Investment Banks
CROs:
Contract Sales Organisations
Universities and Government Research
Testing and Manufacturing Equipment
Packaging Companies

Conference on 6th Annual Drug Delivery Systems Day 1
6th Annual Drug Delivery Systems
Tuesday 1st February 2011

09:00 Registration and refreshments
09:30 Opening address from the chair
09:40 Imagine a patient would run a formulation lab: Patient centered drug delivery product development

From clinical perspectives to therapeutic objectives
Identifying patient needs beyond the clinical symptoms
Translating scientific excellence in real world therapy enhancement
Integrating patient centered drug delivery in healthcare provision

Dr Sven Stegemann
Director, Pfizer

10:20 Realising partnerships with academia, SME’s and Big E in the field of inhalation.
The NeoFor project (New formulation and Devices for the inhalation of Macromolecules)
Anticancer drug project for lung cancer (Solid lipidic micro particles formulations)
Formulations for 2 and 3 molecules
Formulations with pegylated mAb’s
Other projects in partnering

Dr. Michel Deleers
CEO, OncoBel. Former VP New Pharma Technologies & Academic Liaison, UCB New Medicines
11:00 Morning refreshments
11:20 Inhalation delivery systems: the challenges and opportunities

Retention in the lung
Absorption from the lung
Safety and efficacy

Industry challenges & open innovation

Dr. Ben Forbes
Senior Lecturer in Pharmaceutics, King’s College, London

12:00 Sponsor Spotlight Session
Take this unique opportunity to be a part of the conference theme, network, share ideas and provide an overview of your product/services to the audience.
12:40 Networking lunch
13:40 Virtual training course for development of nanoparticulate dosage forms From API to final nanoparticulate drug products

Pros and cons of various particle size reduction technologies

Practical development tools (Stabilizer screening, Particle size measurements, Solid state analysis, Final dosage form manufacturing, Dissolution aspects, Stability studies)

Biopharmaceutical aspects

Dr. Sophie Van Tomme
Pharmaceutical Scientist, Abbott

14:20 Targeted drug delivery using microbubble - An overview
Possible approaches of delivering drug using microbubble
Microbubble production technologies and its effect on delivery
Drug delivery mechanism
Advantages and challenges
Summary
Ketan Pancholi
Lecturer, The Robert Gordon University

15:00 Afternoon Refreshments
15:20 IMAG(IN)E global-release local - IMAGE guided ultra sound-triggered drug delivery for RNAi-based therapy
Medical imaging technologies are becoming an integral part of therapeutic interventions. The development of ultrasound techniques that could non-invasively trigger the delivery of new drug formats such as RNAi therapeutics at a targeted location opens up exciting possibilities for advancing personalized medicine. A key success factor for the effective translation of new drug delivery concepts into clinical practice are partnerships with leading academic, medical institutions and industrial partners.

Philips’ image-guided ultrasound-mediated drug delivery platform offers researchers a unique approach to investigating the delivery of various therapeutic molecules and capitalizes upon Philips’ existing expertise in medical imaging technologies for diagnosis, therapy planning and minimally-invasive medical procedures. We show advances in temperature sensitive liposomes with incorporated drugs and MRI-imaging labels as well as pressure-sensitive microbubbles with specific ultrasound-imaging and drug release characteristics for the local delivery of nucleic-acid based therapeutics including siRNA.

Dr. Oliver Steinbach
Department Head, Philips Research Laboratories

16:00 Ocular Drug Delivery Systems

Challenges and advantages of conventional dosage forms
Analysing recent trends in ocular inserts
Closing remarks from the chair
16:50 Networking drinks

Conference on 6th Annual Drug Delivery Systems Day 2
6th Annual Drug Delivery Systems
Wednesday 2nd February 2011

09:00 Registration and refreshments
09:30 Opening address from the chair
09:40 Targeted drug delivery strategies in cancer therapy: The evolution of early concepts

Naive concepts in early targeting

Toxins as chemotherapeutic agents,

Liposomes as Toxin Vectors

Physiological barriers to success

The emergence of holistic strategies.

Dr. Deirdre McIntosh
Director, McIntosh Scientific Advice Services

10:20 Protein and peptide drug delivery strategies for product lifecycle management

Why is new biologic delivery technologies needed?

Innovative technologies to deliver therapeutic macromolecules:
- CriticalMix – injectable sustained release of macromolecules
- CriticalSorb – systemic delivery of macromolecules via the intranasal route

Dr. Andrew Lewis
Operations Director, Critical Pharmaceuticals

11:00 Morning refreshments
11:20 Drug synthesis and delivery IP due diligence

Importance of IP protecting manufacturing process and drug delivery technology in late stage investments
Typical issues around manufacturing process patents
Typical issues around drug delivery patents
Subsistence of Supplementary Protection Certificates
Regulatory data protection and orphan drug
Protection in late stage investments
Gerry Kamstra
Partner, IP & Life Sciences, Bird and Bird

12:00 Parenteral sustained release drug delivery systems - Status and perspective

Gerrit Hauck
Head PSD R&D Operations, Sanofi-Aventis

12:40 Networking lunch

13:40 Innovations in generic development of drug delivery systems

Drug delivery systems

Challenges in generic development of drug delivery systems
- Regulatory
- IP
- Bio requirements
- Technological

Case studies

Dr. Rajan K. Verma
Senior Manager Early Development Formulations – Generics Integrated Product Development (IPDO)

Dr Reddy’s Laboratories]

14:20 Different strategies in managing a drug delivery alliance
Matthew Roe
Senior Director-Business Development and Licensing, Genzyme

15:00 Afternoon refreshments
15:20 Sponsor Spotlight Session
Take this unique opportunity to be a part of the conference theme, network, share ideas and provide an overview of your product/services to the audience.
16:00 Drug delivery in diabetes
Examining various techniques
Discussing emerging insulin delivery methods
Understanding pricing and reimbursement
16:40 Chair’s closing remarks
16:50 End of Conference

For more please visit
http://www.bharatbook.com/detail.asp?id=111630&rt=Conference-on-6th-Annual-Drug-Delivery-Systems.html

OR Contact us at
Bharat Book Bureau
207, Hermes Atrium, Sector 11, CBD Belapur, Navi Mumbai - 400 614, India.
Phone : +91 22 2757 8668 / 2757 9438
Fax : +91 22 2757 9131
E-mail : info@bharatbook.com
Website : www.bharatbook.com

Sign Up

Sign up for the event